Related Experiment Video
Updated: Nov 2, 2025

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
NAT2 Gene rs1041983 is Associated with Anti-Tuberculosis Drug Induced Hepatotoxicity Among Pediatric Tuberculosis in
Achmad Headriawan1, Alvinsyah Adhityo Pramono2, Abdurachman Sukadi1
1Department of Child Health.
Insights
A specific gene variation, rs1041983 in the NAT2 gene, is linked to a higher risk of drug-induced liver damage in children with tuberculosis. This finding aids in predicting and managing adverse drug reactions in pediatric TB patients.
Area of Science:
- Pharmacogenomics
- Pediatric Infectious Diseases
- Hepatology
Background:
- Pediatric tuberculosis (TB) diagnosis and treatment present global challenges.
- Antituberculosis drug-induced hepatotoxicity (ADIH) can impede treatment success.
- The NAT2 gene, encoding a key enzyme for isoniazid metabolism, is implicated in ADIH, particularly in Asian populations due to specific polymorphisms.
Purpose of the Study:
- To investigate the association between four single nucleotide polymorphisms (SNPs) in the NAT2 gene and ADIH in pediatric TB patients.
- To identify specific NAT2 gene variants that predict ADIH risk in children undergoing TB treatment.
Main Methods:
- A case-control study was conducted with 31 pediatric TB patients experiencing ADIH and 31 controls without ADIH.
- Genomic DNA was analyzed using PCR and sequencing to identify polymorphisms rs1041983, rs1799929, rs1799930, and rs1799931.
- Statistical analysis was performed using Epi Info Ver. 7 software.
Main Results:
- The study identified a significant association between SNP rs1041983 and the occurrence of ADIH in pediatric TB patients (OR 2.39, p=0.019).
- No significant association was found between ADIH and the NAT2 polymorphisms rs1799929 (p=0.133), rs1799930 (p=0.150), or rs1799931 (p=0.659).
Conclusions:
- The NAT2 gene polymorphism rs1041983 is significantly associated with the occurrence of ADIH in pediatric TB patients.
- This finding highlights the potential of rs1041983 as a predictive biomarker for ADIH in this population.
Background:
As pediatric tuberculosis (TB) globally is still reported challenging in diagnosis, to date, a lot of efforts have been established to eliminate the disease including proper treatment regimen using anti-TB drugs. However, antituberculosis drug-induced hepatotoxicity (ADIH) is known to interfere the success of the prescribed therapy. ADIH was found to be correlated with polymorphisms of NAT2 gene, that is responsible to transcript the NAT2 enzyme, a metabolizer of isoniazid (INH). The most common NAT2 gene polymorphisms in Asian population associated with ADIH are rs1041983, rs1799929, rs1799930 and rs1799931. The study aimed to investigate the 4 single nucleotide polymorphisms (SNPs) in pediatric TB that experienced ADIH.
Methods:
We conducted a case-control study comparing 31 each of pediatric TB experience with and without ADIH. All pediatric TB was selected from 451 pediatric TB Registry of Respirology Division, Department of Child Health Faculty of Medicine Universitas Padjadjaran/Dr Hasan Sadikin Hospital during January 2016 to July 2018. Genomic DNA PCR and sequencing to identify polymorphisms of rs1041983, rs1799929, rs1799930 and rs1799931 were performed in both groups. Data analysis was performed using the Epi info Ver. 7 software.
Results:
Thirty-one pediatric TB experiences with and without ADIH were enrolled in this study. SNP rs1041983 significantly affected the occurrence of ADIH (OR 2.39, CI 95% (1.15-4.96), p=0.019). The rs1799929, rs1799930 and rs1799931 did not significantly affect the occurrence of ADIH (p=0.133, p=0.150 and p=0.659, respectively).
Conclusion:
Polymorphism SNP rs1041983 had association with the occurrence of ADIH.
More Related Videos
06:07Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
Published on: June 6, 2025
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: